1. Home
  2. Courses
Skip to main content
eLearning on BoehringerOne
The Why of Empagliflozin: Putting every diagnosed HF patient on SGLT2i [HF Experts’ Perspectives]

The Why of Empagliflozin: Putting every diagnosed HF patient on SGLT2i [HF Experts’ Perspectives]